About the Company
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung and liver failure.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $TMDX News
TransMedics Group, Inc. (TMDX) Q4 2022 Earnings Call Transcript
I would now like to turn the conference over to Brian Johnston from Gilmartin Group. Please go ahead. Thank you. Earlier today, TransMedics released financial results for the quarter and full year ...
Market Sentiment Around Loss-Making TransMedics Group, Inc. (NASDAQ:TMDX)
We feel now is a pretty good time to analyse TransMedics Group, Inc.'s (NASDAQ:TMDX) business as it appears the company may be on the cusp of a considerable accomplishment. TransMedics Group, Inc., a ...
TransMedics: Triple-Digit Revenue Growth Supports Repricing In FY 2023
Triple-digit growth in top-line sales for the quarter and the year evidence the market's approval for TransMedics Group, Inc.'s offerings. TransMedics Group is addressing operational efficiencies ...
Top Healthcare Stocks for March 2023
Top healthcare stocks include Theravance Biopharma for best value, Signify Health for fastest growth, and TransMedics Group ...
TransMedics: Q4 Earnings Snapshot
ANDOVER, Mass. (AP) — ANDOVER, Mass. (AP) — TransMedics Group Inc. (TMDX) on Wednesday reported a loss of $6.7 million in its fourth quarter. The Andover, Massachusetts-based company said it ...
Calculating The Fair Value Of TransMedics Group, Inc. (NASDAQ:TMDX)
The projected fair value for TransMedics Group is US$66.10 based ... one way of estimating the intrinsic value of TransMedics Group, Inc. (NASDAQ:TMDX) by taking the expected future cash flows ...
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
ANDOVER, Mass., Feb. 24, 2023 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with ...
TransMedics to Present at Upcoming March Investor Conferences
About TransMedics Group, Inc. TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover ...
TransMedics Group, Inc.: TransMedics Reports Fourth Quarter and Full Year 2022 Financial Results
TransMedics Group, Inc. CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except share and per share data) (unaudited) Three Months Ended December 31, Year Ended December 31, 2022 2021 2022 ...
Loading the latest forecasts...